[1]
A. Akef, “Impact of Molecular and Cytogenetic Risk Stratification, Early Treatment Response, and Inflammatory Biomarkers on Survival in Intensively Treated Non-Acute Promyelocytic Leukemia Acute Myeloid Leukemia”, World J Oncol, vol. 17, no. 6, pp. 886–897, Jan. 2026, doi: 10.14740/wjon2856.